Please login to the form below

Not currently logged in
Email:
Password:

Lilly partners with Wal-Mart

Eli Lilly has partnered with retailer Wal-Mart to sell an affordable version of the pharma company's Humulin synthetic human insulin product for diabetes

Eli Lilly has partnered with Wal-Mart, the country's largest retailer, to sell an affordable version of the pharma company's Humulin synthetic human insulin product for diabetes in nationwide Wal-Mart pharmacies. The deal represents the first time that Lilly has partnered with a retail pharmacy on a co-branded product.

The product, which will be available to consumers starting in mid-September, will be sold under the dual-branded name Humulin ReliOn.

Wal-Mart, which has more than 4,300 US stores, already offers a number of $9 diabetes management products under the ReliOn brand, including the ReliOn Ultima Blood Glucose Meter, ReliOn Ultima Blood Glucose Test Strips, and the ReliOn A1c test.

Lilly's Humulin generated worldwide sales of $1bn last year, but is being overshadowed by an even bigger moneymaker, the company's newer Humalog insulin, which brought in $2bn during the same period.

23rd June 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics